Hi [[ session.user.profile.firstName ]]

Direct Oral Anticoagulants for the Treatment of Cancer Associated VTE

About this Webinar
This webinar will discuss the increased incidence of venous thromboembolism in cancer patients and the safe and effective use of oral anticoagulants to improve outcomes. Chaired by Prof Jonathan Sackier, we will learn about the importance of raising awareness in both oncologists and cancer patients regarding the increased risks of venous thromboembolism and the signs and symptoms to look for. Dr Mark Carrier and Dr Harry Gibbs will discuss the most effective treatment pathways with a Q&A session hosted by Prof Sackier.

The speakers:

Dr Jonathan Sackier
United Kingdom
Dr Sackier is an internationally renowned surgeon, technology innovator, entrepreneur and presenter of the EMG-Health Podcast. He has founded several successful medical technology start-ups.

Dr Marc Carrier
The Ottawa Hospital, Ottawa, Canada

Dr Marc Carrier is Head of the Division of Hematology in the Department of Medicine at The Ottawa Hospital. He is also a Professor in the Faculty of Medicine, University of Ottawa, and a Senior Scientist in the Clinical Epidemiology Program of The Ottawa Hospital Research Institute. His research focus is venous thromboembolic disease and cancer, including cancer screening, prevention and management. In 2015 he was the recipient of the prestigious Dr. Michel Chrétien Researcher of the Year Award for his study published in the New England Journal of Medicine that improves care for VTE patients around the world.

Dr Harry Gibbs
The Alfred Hospital, Melbourne, Australia.
Dr Harry Gibbs is currently the Program Director of Outpatients Program, and Deputy Director of General Medicine in The Alfred Hospital, Melbourne, as well as Adjunct Clinical Associate Professor at Monash University. His interests are cardiovascular and general medicine, with a particular interest in thrombosis and anticoagulant therapy. Dr Gibbs is currently a board member of The Australian and New Zealand Society for Vascular Surgery.
Recorded Jun 28 2021 71 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Dr. Jonathan Sackier
Presentation preview: Direct Oral Anticoagulants for the Treatment of Cancer Associated VTE

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • Genomic Profiling for Treatment Plans for Women with Early Stage Breast Cancer Sep 30 2021 3:00 pm UTC 75 mins
    Chair: Dr. Jonathan Sackier, Speakers: Dr. William Audeh, Dr. Alberto Montero
    Allow HCP's within Oncology to;
    • Understand the latest data supporting the utility of Agendia’s assays: MammaPrint® and BluePrint® for ER+ patients
    • Review and appreciate the real-world impact of MammaPrint and BluePrint.
    • Recommend genomic profiling for pre-and post-operative breast cancer treatment planning
  • Acute MSK pain: how to manage symptoms and stress Recorded: Jul 15 2021 69 mins
    Dr Jonathan Sackier
    Musculoskeletal (MSK) pain and soft tissue injuries are very common both in sportspeople and in general population and include different forms of traumas (sprains, strains, contusions as well as back pain) that must be properly treated to allow the return to normal life or sport activities.
    From the pharmacological point of view, non-steroidal anti-inflammatory drugs (NSAIDs) play an important role thanks to their efficacy on many forms of MSK pain, with a good benefit/risk profile.
    However, pain is a complex phenomenon where psychological aspects may also have a great impact on the way we overcome it.

    The aim's of the Webinar today are:
    - To present the advances in topical NSAIDs therapy, together with the discussion of clinical cases
    - To understand the perception of pain in sportspeople and how pain and adversities can even make us stronger

    This session is to be moderated by Dr. Jonathan Sackier, featuring our two speakers:
    Dr. Todd Stitik - Department of Physical Medicine & Rehabilitation, Rutgers New Jersey, Medical School, Newark, US
    Dr. Luca Sighinolfi - Performance Coach and Psychologist Trainer PhD, Performance & Business Psychology, Bergamo, Italy
  • Diclofenac in a New and Innovative Form: Low Dosages and Small Volume Recorded: Jun 30 2021 52 mins
    Dr. Jonathan Sackier
    Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. Unfortunately, it is a symptom associated with many clinical situations of different nature and its management is even today a complex issue. In this scenario, NSAIDs have always been a milestone in the treatment of pain, even if they have evolved little in recent years.

    In this webinar Dr. Jonathan Sackier is joined by Dr. Alia Darweish Medniuk and Dr. Juraj Kacian as they discuss the importance of the NSAID diclofenac for the management of pain in different settings/clinical situations. They will also highlight what’s new for diclofenac, namely the development of new formulations at small volume and low dosages, in line with the EMA recommendations on NSAIDs and CV risk
  • A Novel Algorithm to Treat Chronic Coronary Total Occlusions Recorded: Jun 29 2021 38 mins
    Pierfrancesco Agostoni
    In this webinar, Pierfrancesco Agostoni, Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp, Belgium presents a simpler and more efficient approach for percutaneous coronary intervention (PCI) of chronic coronary total occlusion (CTO), termed the Minimalistic Hybrid Approach (MHA). Agostoni discusses how MHA helps to downsize the set-up procedure but also helps to achieve minimal invasiveness by improving elements such as the access site, dual injection, and introducer size, while at the same time maintaining the efficiency and success rate of the classic algorithm approach.
  • Direct Oral Anticoagulants for the Treatment of Cancer Associated VTE Recorded: Jun 28 2021 71 mins
    Dr. Jonathan Sackier
    About this Webinar
    This webinar will discuss the increased incidence of venous thromboembolism in cancer patients and the safe and effective use of oral anticoagulants to improve outcomes. Chaired by Prof Jonathan Sackier, we will learn about the importance of raising awareness in both oncologists and cancer patients regarding the increased risks of venous thromboembolism and the signs and symptoms to look for. Dr Mark Carrier and Dr Harry Gibbs will discuss the most effective treatment pathways with a Q&A session hosted by Prof Sackier.

    The speakers:

    Dr Jonathan Sackier
    United Kingdom
    Dr Sackier is an internationally renowned surgeon, technology innovator, entrepreneur and presenter of the EMG-Health Podcast. He has founded several successful medical technology start-ups.

    Dr Marc Carrier
    The Ottawa Hospital, Ottawa, Canada

    Dr Marc Carrier is Head of the Division of Hematology in the Department of Medicine at The Ottawa Hospital. He is also a Professor in the Faculty of Medicine, University of Ottawa, and a Senior Scientist in the Clinical Epidemiology Program of The Ottawa Hospital Research Institute. His research focus is venous thromboembolic disease and cancer, including cancer screening, prevention and management. In 2015 he was the recipient of the prestigious Dr. Michel Chrétien Researcher of the Year Award for his study published in the New England Journal of Medicine that improves care for VTE patients around the world.

    Dr Harry Gibbs
    The Alfred Hospital, Melbourne, Australia.
    Dr Harry Gibbs is currently the Program Director of Outpatients Program, and Deputy Director of General Medicine in The Alfred Hospital, Melbourne, as well as Adjunct Clinical Associate Professor at Monash University. His interests are cardiovascular and general medicine, with a particular interest in thrombosis and anticoagulant therapy. Dr Gibbs is currently a board member of The Australian and New Zealand Society for Vascular Surgery.
  • The Treatment of HR+ Early-Stage Breast Cancer Recorded: Jun 24 2021 56 mins
    Dr. Ivana Sestak
    Hear from the experts in the field of early-stage breast cancer on the performance and
    utility of the Prosigna® breast cancer prognostic gene signature. From current to
    emerging treatment options, the speakers will discuss different biomarker strategies
    that support shared decision-making for the management of hormone-receptor positive
    (HR+) patients.
  • A Novel Algorithm to Treat Chronic Coronary Total Occlusions Recorded: Jun 22 2021 38 mins
    Pierfrancesco Agostoni
    In this webinar, Pierfrancesco Agostoni, Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp, Belgium presents a simpler and more efficient approach for percutaneous coronary intervention (PCI) of chronic coronary total occlusion (CTO), termed the Minimalistic Hybrid Approach (MHA). Agostoni discusses how MHA helps to downsize the set-up procedure but also helps to achieve minimal invasiveness by improving elements such as the access site, dual injection, and introducer size, while at the same time maintaining the efficiency and success rate of the classic algorithm approach.
  • Advanced Tests for Sperm Analysis and Diagnosis of Male Infertility Recorded: Jun 21 2021 52 mins
    Elisabetta Baldi
    In this on-demand webinar, Prof Elisabetta Baldi discusses the role of advanced tests for sperm analysis in the diagnosis of male infertility, focussing on sperm DNA fragmentation and other tests that can be of help for diagnostic purposes.
  • Striving for better clinical outcomes in uncontrolled seizures Recorded: Jun 16 2021 64 mins
    Dr Jonathan Sackier
    Join us for a thought-provoking online webinar, in the strive for better clinical outcomes in uncontrolled seizures.
    The key topics of discussion will be:
    Are uncontrolled seizures life-threatening?
    What’s next once your epilepsy patient is drug resistant?
    Partnering with epilepsy centers in patient care

    Sharing their expert opinions will be:
    Prof. Kristl Vonck, Professor of Neurology, Ghent University, Belgium
    Prof. Arjune Sen, Consultant Neurologist at The John Radcliffe Hospital, Oxford, UK
    Dr. Richard Selway, Lead for the Department of Neurosurgery at King’s College Hospital, London, UK
    Dr. Stephan Hinze, Consultant Neurologist, Great Western Hospital & John Radcliffe Hospital Oxford, UK

    Leading up to the webinar, take part in our survey here:
    https://epilepsy.livanova.com/eu/are-uncontrolled-seizures-life-threatening
  • Beyond PSA: Utility of a Urine Gene Expression Recorded: May 27 2021 53 mins
    Prof. Alexander Kretschmer
    Prostate cancer is a leading cause of cancer in men, affecting more than 1 million men in the world and resulting in 300,000 deaths annually. Most guidelines now support shared decision making around the question of prostate cancer early detection—but how exactly to do this remains controversial.

    The conversations can be confusing, especially during a time when appointments and procedures have been canceled and COVID-19 has upended our normal way of practicing, leaving both patients and physicians scrambling for answers. PSA remains the gold standard as a first-line screening test, but is limited in terms of specificity, especially among older men. We now have available new, non-invasive biomarkers which can help men decide whether to proceed with biopsy, in order to find high-grade, potentially lethal tumors early while minimizing over diagnosis of low-grade, indolent tumors.

    Webinar Objectives:
    • Understand the basics of exosomes and exosome-based diagnostic tools;
    • Learn why an exosome-based liquid-biomarker approach offers an ideal platform for the early risk assessment of high-grade prostate cancer;
    • Compare the performance of various biomarkers and how they fit into clinical practice;
    • Determine which patients would most benefit from the ExoDx Prostate (EPI) test as risk assessment tool.
  • Advanced Tests for Sperm Analysis and Diagnosis of Male Infertility Recorded: May 25 2021 52 mins
    Elisabetta Baldi
    This webinar led by Prof Elisabetta Baldi which will be based on advanced tests for sperm analysis: their role in the diagnosis of male infertility. Discussions will be based on sperm DNA fragmentation and other tests that can be of help for diagnostic purposes of male infertility.
  • Diclofenac in a New and Innovative Form: Low Dosages and Small Volume Recorded: May 20 2021 52 mins
    Dr. Jonathan Sackier
    Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. Unfortunately, it is a symptom associated with many clinical situations of different nature and its management is even today a complex issue. In this scenario, NSAIDs have always been a milestone in the treatment of pain, even if they have evolved little in recent years.

    In this webinar Dr. Jonathan Sackier is joined by Dr. Alia Darweish Medniuk and Dr. Juraj Kacian as they discuss the importance of the NSAID diclofenac for the management of pain in different settings/clinical situations. They will also highlight what’s new for diclofenac, namely the development of new formulations at small volume and low dosages, in line with the EMA recommendations on NSAIDs and CV risk
  • Holmium Laser Enucleation of the Prostate (HoLEP) Recorded: Apr 28 2021 44 mins
    Ben Challacombe
    In this surgical webinar Ben Challacombe, Guy’s Hospital & King’s College London, UK, demonstrates the Holmium Laser Enucleation of the Prostate (HoLEP) method for a patient with hypertrophic prostate and severe lower urinary tract symptoms.

    To introduce the webinar, Challacombe provides an overview of the setup and technical equipment required, before going on to demonstrate the full procedure and describe the techniques used. He shares tips and tricks for how to address heavy bleeding, what level of laser power to use, and how to position the laser, and describes common mistakes in the technique and how to avoid them.

    This is a must-watch for urologists and trainee urologists wishing to expand their knowledge of this challenging but rewarding procedure.
  • Robotic Transperitoneal Adenomectomy for BPH Recorded: Mar 10 2021 39 mins
    Prof. Dr. A. Erdem Canda
    In this webinar focusing on robotic urology, you will have the opportunity to watch a robotic adenomectomy being performed on a patient with benign prostatic hyperplasia. The procedure is performed by Prof. A Erdem Canda from Koç University Hospital in Turkey, who will talk the audience through the different steps. At the end of the presentation the audience will have the opportunity to interact with the speaker in a live Q&A session.
The go to place for healthcare professionals
Our webinars provide engaging and educational content for healthcare professionals, featuring a range of stimulating presentations, thought-provoking interviews with industry experts, and news and updates from the field.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Direct Oral Anticoagulants for the Treatment of Cancer Associated VTE
  • Live at: Jun 28 2021 12:00 pm
  • Presented by: Dr. Jonathan Sackier
  • From:
Your email has been sent.
or close